Assessment of Pulmonary
Pressures and Right Heart
Function
Jeffrey B. Geske, M.D.
Geske.Jeffrey@mayo.edu
©2018 MFMER | 3664386-1
Assessment of Pulmonary Pressures
and Right Heart Function
Jeffrey B. Geske, MD
©2018 MFMER | 3664386-2
1
Disclosure
• No disclosures
©2017 MFMER | 3664386-3
Learning Objectives
• Simplify echocardiographic assessment of pulmonary
hemodynamics
• Review quantitation of right ventricular size and function
• Discuss echocardiographic prognostic findings in pulmonary
hypertension
• Clarify mechanistic differentiation of PH by
echocardiography
©2017 MFMER | 3664386-4
2
Pulmonary Hypertension – Outline
Echo Evaluation
Disease
Severity
PH? / Mechanism
Pressures
Echo
in PH
©2017 MFMER | 3664386-5
28 y/o Female Presents with Dyspnea,
Syncope and Lower Extremity Edema
RV
LV
©2017 MFMER | 3664386-6
3
28 y/o Female Presents with Dyspnea,
Syncope and Lower Extremity Edema
©2017 MFMER | 3664386-7
Hemodynamics
©2017 MFMER | 3664386-8
4
25
Pressure (mm Hg)
20 Pulmonary
artery
15 pressure
Right
10 ventricular
Right atrial pressure
5
pressure
0 +
0.0 0.2 0.4 0.6 0.8 1.0
+ + +
Seconds
RVSP = 4 (VTR)2 + RAP
RV systolic pressure = PA systolic pressure
(in the absence of pulmonary stenosis)
©2017 MFMER | 3664386-9
Overestimating RV Systolic Pressure
Rich Imagination and Overgained Signals
©2017 MFMER | 3664386-10
10
5
Overestimating RV Systolic Pressure
Don’t measure the fuzz!
2.9 vs. 3.6 i.e. 34 mmHg vs. 52 mmHg 3.5 vs. 4.8 i.e. 49 mmHg vs. 92 mmHg
TR Tips:
Avoid overgained, fuzzy signals
Use contrast if needed
Modal signal
©2017 MFMER | 3664386-11
11
RA Pressure
• Don’t base estimate on an arbitrary value
• Base on 2D and Doppler imaging of the IVC and hepatic veins
©2017 MFMER | 3664386-12
12
6
IVC Measurement
Rudski LG et al: J Am Soc Echocardiogr: 23;685, 2010
©2017 MFMER | 3664386-13
13
Assessment of Right Atrial Pressure
Based on IVC and Hepatic Vein Imaging
HV PW Doppler
• normal IVC dimension (≤21 mm)
5 mmHg • normal (>50%) collapse with sniff/inspiration
10 mmHg • normal IVC with reduced collapse
15 mmHg • Dilated IVC with normal collapse
• Severely dilated IVC & hepatic veins
20 mmHg • Little or no collapse with sniff/inspiration
Mayo Clinic
©2017 MFMER | 3664386-14
14
7
Assessment of Right Atrial Pressure
Based on IVC and Hepatic Vein Imaging
HV PW Doppler
• normal IVC dimension (≤21 mm)
3 mmHg • normal (>50%) collapse with sniff/inspiration
• normal IVC with reduced collapse
8 mmHg
• Dilated IVC with normal collapse
• Severely dilated IVC & hepatic veins
15 mmHg • Little or no collapse with sniff/inspiration
Simplified version recommended by ASE. Guidelines, 2010
Rudski LG et al: J Am Soc Echocardiogr: 23;685, 2010
©2017 MFMER | 3664386-15
15
Estimated RVSP with Wide-Open TR
©2017 MFMER | 3664386-16
16
8
Estimated RVSP with Wide-Open TR
• TR velocity is typically low
as little pressure gradient
between RA and RV
• Ventricularization of RA
pressures
• Proximal velocity no
longer <<< distal velocity
RVSP = 4 (VTR)2 + RAP
©2017 MFMER | 3664386-17
17
Estimated RVSP with Wide-Open TR
RA pressure typically very high
Hard to accurately predict
©2017 MFMER | 3664386-18
18
9
Pulmonary Hypertension Definition
PH = mean pulmonary artery pressure
≥25 mm Hg
©2017 MFMER | 3664386-19
19
Relationship of PA Systolic and PA Mean Pressure
100 0.67 * PASP +0.5 Mean PAP ≈ 2/3rds systolic PAP
PA mean pressure, mmHg
90 r= 0.96, p<0.0001
80 n=534
70
(by cath)
60
50
40
30
20
10
0
0 25 50 75 100 125 150
PA systolic pressure, mmHg (by cath)
Courtesy of Dr. G Kane
©2017 MFMER | 3664386-20
20
10
Mean Pulmonary Artery Pressure
The most reproducible method
to calculate mean PA pressure
is based on the mean Doppler
gradient of the tricuspid
regurgitant (TR) signal
PAPm = TRmn gr + RAP
Adeun JF et al: J Am Soc Echocardiogr: 22;814, 2009
©2017 MFMER | 3664386-21
21
Pulmonary Artery Diastolic Pressure
25 Pulmonary
Pressure (mm Hg)
artery
20 Diastole pressure
15
Right
10 ventricular
pressure
5
0
0.6 0.8 1.0 0.2 0.4 0.6 0.8 1.0
Seconds
PADP = 4 (VePR)2 + RAP
©2017 MFMER | 3664386-22
22
11
Mean PA Pressure
Peak PR velocitymax = 3 m/s
PAPm = 4 (Vpeak PR)2 + RAP
©2017 MFMER | 3664386-23
23
Patient with Pulmonary Hypertension
Normal IVC Size with Near Complete Collapse
RVSP = 4 (VTR)2 + RAP = 4(4)2 + 3 = 67
PADP = 4 (VePR)2 + RAP = 4(2)2 + 3 = 19
PAPm = TRmn gr + RAP = 35 + 3 = 38
©2017 MFMER | 3664386-24
24
12
Echo Assessment of PH: 67/19/38
100
RHC: 90/28/54 RHC: 68/23/39
80
60
40
20
Room air 2L/min nasal oxygen
0
O2 Sats 87% O2 Sats 93%
O2 sat ➔ vasoconstriction & PH
Perform the echo on oxygen
©2017 MFMER | 3664386-25
25
Pulmonary Hypertension – Outline
Echo Evaluation
Disease
Severity
PH? / Mechanism
Pressures
Echo
in PH
©2017 MFMER | 3664386-26
26
13
In a patient with pulmonary hypertension, which of the
following factors LEAST predict outcome?
1. Pulmonary artery pressures
2. Right ventricular size
3. Right ventricular function
4. Left ventricular size
5. Presence of a pericardial effusion
©2017 MFMER | 3664386-27
27
In a patient with pulmonary hypertension, which of the
following factors LEAST predict outcome?
1. Pulmonary artery pressures
2. Right ventricular size
3. Right ventricular function
4. Left ventricular size
5. Presence of a pericardial effusion
©2017 MFMER | 3664386-28
28
14
©2017 MFMER | 3664386-29
29
How Do You Define Severity of PH?
• Mild PH → RVSP 40 – 55 mm Hg
• Moderate PH → RVSP 55 – 70 mm Hg
• Severe PH → RVSP > 70 mm Hg
©2017 MFMER | 3664386-30
30
15
PAH: A Progressive Disease
Outcome Poorly Predicted by PA Pressures
Pre-symptomatic Symptomatic Declining
Compensated decompensating Decompensated
CO
Symptom Threshold
PAP
Time
©2017 MFMER | 3664386-31
31
How Do You Define Severity of PH?
• Mild PH → RVSP 40 – 55 mm Hg
• Moderate PH → RVSP 55 – 70 mm Hg
• Severe PH → RVSP > 70 mm Hg
• Don’t define severity of PH based on pressure alone
• Integrate pressure with other data including right heart function
©2017 MFMER | 3664386-32
32
16
Right Ventricular Afterload
PVR = (Mean PAP – PCWP) / CO
Reflects the arterial load to steady flow
• Doppler correlate:
PVR = Peak TRvel / RVOT TVI x 10
Does not incorporate LV filling pressure
The echo-derived PVR should not be used as a
substitute for an invasive PVR assessment
©2017 MFMER | 3664386-33
33
Right Ventricular Afterload
Compliance / Capacitance
• Can be estimated by SV / PA pulse pressure
• May be as (more) important in PH as resistance
Stroke Volume LVOT Area X TVI
PVCAP = =
Pulse Pressure* 4 (TR Vmax2 – PRend V2)
*PA systolic – PA diastolic
Mahapatra S et al: J Am Soc Echocardiogr: 19;1045, 2006
©2017 MFMER | 3664386-34
34
17
“W Sign” – High RV Afterload
Normal PH
• Late onset of flow
• Early time to peak
• Mid systolic notching
• Reduced overall TVI
©2017 MFMER | 3664386-35
35
Key Points About PA Pressures
• Accuracy of echo info is largely technical
• Avoid overgained TR signals
• Base RA pressure on echo data
• PA pressures important but not prognostic in PH
• Don’t look at one parameter in isolation
©2017 MFMER | 3664386-36
36
18
Pulmonary Arterial Hypertension
Survival in the Modern Era
100 Consecutive series
80 of PAH who died
Survival (%)
60 Non PH causes
Progressive RVF
40
Sudden death
20 (severe RV dysfxn)
Secondary cause
0 PH/RVF contributed
0 1 2 3 4 5 6 7 8
Follow-up, years
Kane GC et al: CHEST June; 139 (6), 2011
©2017 MFMER | 3664386-37
37
Right Ventricular Size
©2017 MFMER | 3664386-38
38
19
Challenging Geometry of the RV
RV Normal
RV
Pulmonary
LV Hypertension
LV
LV LV
RV RV
RA RA
LA LA
©2017 MFMER | 3664386-39
39
Appropriate RV imaging
Obtain an RV Apical 4 Chamber View
LV centric RV centric
©2017 MFMER | 3664386-40
40
20
Right Ventricular Size
Qualitative
Normal Mild RVE Moderate RVE Severe RVE
2/3 size of LV Similar to LV Larger than LV Very large
Shares apex D-shaped septum
©2017 MFMER | 3664386-41
41
RV Size Quantitation
• Length (>83 mm* ) RV
• Mid diameter (>35 mm* )
• Basal diameter (>41 mm* ) LV
*Measures indicate dilatation
Tips
• Measure at end-diastole from an RV-focused RA
apical 4-chamber view LA
• Optimize image to have maximum diameter
without foreshortening the ventricle
Lang RM et al: J Am Soc Echocardiogr: 28;1, 2015
©2017 MFMER | 3664386-42
42
21
Right Ventricular Function
©2017 MFMER | 3664386-43
43
RV Function
• Patients do not die of PH, they invariably die of the
failure of the RV to compensate for the PH
• There is no gold standard measure of RV function
• CT and MRI better for RVEF
• Many echo parameters of RV function predict outcome
in patients with PH
©2017 MFMER | 3664386-44
44
22
RV Index of Myocardial Performance (RIMP)
Global Indicator of Systolic and Diastolic Function
TV Closure to Open time
RIMP =
(IVCT + IVRT) TVCOt – RV ET
=
RV ET RV ET
• Relatively independent of HR, preload or afterload
• Prognostic in PH
• May be falsely low if RAP high (which will ↓ IVRT)
IVCT IVRT
RVOT
ejection time
Tei C et al: J Am Soc Echocardiogr: 9;838, 1996
©2017 MFMER | 3664386-45
45
Visual Assessment of Ventricular Function
LV RV
©2017 MFMER | 3664386-46
46
23
Predominant Longitudinal
Fiber Orientation in the RV
Unlike the LV, the RV lacks
significant endocardial and
epicardial transverse layers
©2017 MFMER | 3664386-47
47
RV Function by 3D Echo
• Unlike LV, radial contractility of RV is modest
• Predominant RV motion is longitudinal (base towards apex)
©2017 MFMER | 3664386-48
48
24
Simple Measures of Longitudinal Shortening
TAPSE and TDI
Both prone to translational error
TAPSE (≥20mm)
ES
ED
End-diastole End-systole Systolic velocity (≥15cm/sec)
• Simple S’
• Specific, modestly sensitive
• Prognostic in PAH
Fiorfia P et al: Am J Respir Crit Care Med;174:1034, 2006
©2017 MFMER | 3664386-49
49
RV Free Wall Longitudinal Peak Systolic Strain
• Sensitive and reproducible Abnormal: Less
• Angle independent Negative than -25%
• Not prone to translational motion
• Prognostic in PAH, superior to other
measures
©2017 MFMER | 3664386-50
50
25
RV Strain Predicts Outcomes in PH
Time Free of Cardiac Events
All-Cause Mortality or PH Medical Intervention
Time free from cardiac event or
PH medical intervention (%)
50 <-15% (severe reduction) 100
All-cause mortality (%)
-15 to -20% (moderate reduction)
40 -20 to -24% (mild reduction) 80
25% (normal)
30 60
20 40
P<0.001 P<0.001
10 20
0 0
0 2 4 6 8 10 12 14 16 18 0 2 4 6 8 10 12 14 16 18
Follow-up, months Follow-up, months
Fine NM et al: Circ Cardiovasc Imag; 6:711, 2013
©2017 MFMER | 3664386-51
51
Pericardial Effusion
Bad Sign in Pulmonary Hypertension
100
Mod or greater effusion
80
Mortality (%)
Mild effusion
60
40
No effusion
20
0
0 1 2 3 4 5
Follow-up, years
Mortality rates a reflection of high venous pressure rather than risk of tamponade
©2017 MFMER | 3664386-52
52
26
Findings Associated with Poor Prognosis in PAH
Structure RV Function Other
RV dilation RV systolic strain RA pressure
RA dilation TAPSE Pericardial effusion
Decrease in LV size Tissue Doppler Delayed relax pattern
RIMP PA capacitance
Cardiac output Severe TV regurgitation
PA pressures correlate poorly with outcome
©2017 MFMER | 3664386-53
53
Pulmonary Hypertension – Outline
Echo Evaluation
Disease
Severity
PH? / Mechanism
Pressures
Echo
in PH
©2017 MFMER | 3664386-54
54
27
Pulmonary Hypertension
Classification
Group 1
Pulm arterial hypertension Group 2
Setting of LH Disease
• Idiopathic (primary PH)
• Familial/genetic
• Drug/toxin related Group 3
Hypoxia/Lung Disease
• Scleroderma
• Portopulmonary
• HIV Group 4
Chr Thromboembolic Disease
• Congenital sys – pulm shunts
©2017 MFMER | 3664386-55
55
Pulmonary Hypertension
Classification by Echo
Pre-capillary PH Post-capillary PH
Group 1
Pulmonary Arterial Hypertension
Hemodynamics
Group 3 similar
Group 2
Hypoxia/Lung Disease Setting
FindingsofonLHEcho
Disease
and
RHC are
Group 4 indistinguishable
Chr Thromboembolic Disease
©2017 MFMER | 3664386-56
56
28
PH – Is It Pulmonary Venous Hypertension?
Usually easy by history, exam and echo
• Low LVEF
• Severe MR, MS, AS
PAH vs HFpEF with PH can be difficult
• Afib, LA enlargement, LVH – all suggest HFpEF
• Some echo features of ‘diastolic dysfunction’ can be
caused by a bad right heart (i.e. seen with PAH)
• Echo PVR calculations do not encompass LA pressure –
they do not distinguish PAH from PVH
©2017 MFMER | 3664386-57
57
©2017 MFMER | 3664386-58
58
29
Take Home Points
• RVSP = 4VTR2 + RAP
• Don’t overgain or measure fuzz
• Don’t use in wide open TR
• RV longitudinal motion is major contributor to systolic
function
• RV function is key for survival in PH
• Assess the left heart to determine mechanism of PH,
don’t rely on PVR by echo
©2017 MFMER | 3664386-59
59
geske.jeffrey@mayo.edu
@jeffreygeske
©2017 MFMER | 3664386-60
60
30